tiprankstipranks
Exact Sciences Corp. (EXAS)
NASDAQ:EXAS
Holding EXAS?
Track your performance easily

Exact Sciences (EXAS) Stock Investors

3,170 Followers
Based on 769,291 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

0.2% of all portfolios hold EXAS
On average, investors allocate 2.88% of their portfolios to EXAS
The average holding size of this company in investors' portfolios.

Investor Sentiment

Neutral
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 769,291 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding EXAS

1.0%
Last 7
Days
0.5%
Last 30
Days
Percentages indicate the change in the number of portfolios holding EXAS, out of 769,291 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

EXAS Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Opened
14.29%
$44.82
Increased
0.49%
$69.34
Increased
3.63%
$44.09
Reduced
2.26%
$71.51
Reduced
8.63%
$59.70
Increased
0.89%
$52.70
Opened
0.00%
$61.69
Opened
0.00%
$61.69
Opened
0.00%
$61.69
Opened
0.00%
$61.69
Based on the activity of 14,697 investors who made their portfolios public
The table shows changes in EXAS in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

EXAS Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Block
4.40%
-0.22%
+2.93%
57.46B
Technology
DraftKings
5.48%
-1.70%
+0.74%
38.35B
Consumer Cyclical
Enphase Energy
4.56%
-0.05%
+0.53%
8.59B
Technology
Zscaler
3.69%
-1.61%
-2.60%
31.61B
Technology
Trade Desk
4.80%
-0.99%
+1.61%
62.86B
Technology
Applied Materials
3.99%
+0.69%
+3.93%
144.89B
Technology
BlackRock
4.66%
+0.33%
+7.02%
159.22B
Financial
Bristol-Myers Squibb
3.55%
-0.55%
-1.06%
118.10B
Healthcare
Airbnb
4.32%
-1.86%
-1.70%
84.48B
Consumer Cyclical
Carnival
6.41%
+0.45%
+9.28%
31.76B
Consumer Cyclical
Based on the activity of 769,291 active portfolios
Open your Smart Portfolio

EXAS Investor Analysis

EXAS investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
12.1%
of EXAS holders
are under 35
Average Segment Performance
Average P/E Ratio29.47
Beta10.82
Dividend Yield99.38%
EXAS investors between 35–55

Between 35–55

3.4%
Last 30 days
Holdings Change
45.2%
of EXAS holders
are between 35–55
Average Segment Performance
Average P/E Ratio26.86
Beta20.87
Dividend Yield46.37%
EXAS investors over 55

Over 55

1.7%
Last 30 days
Holdings Change
42.7%
of EXAS holders
are over 55
Average Segment Performance
Average P/E Ratio25.26
Beta9.51
Dividend Yield77.60%
Overview of age group and performance of EXAS stock investors
See who invests in EXAS according to age group and performance.

FAQ

How many retail Investors hold EXAS?
0.2% of TipRanks' retail investors hold EXAS in their portfolios.
    What is EXAS Investor Sentiment?
    EXAS’s Investor Sentiment is Neutral.
      What percentage of retail investors changed their holding of EXAS in the last 7 days?
      ▼ 1.0% of TipRanks' retail investors changed their holding of EXAS in the last 7 days.
        What percentage of retail investors changed their holding of EXAS in the last 30 days?
        ▲ 0.5% of TipRanks' retail investors changed their holding of EXAS in the last 30 days.
          What is the average age of retail investors who hold EXAS?
          The average age of EXAS Holders is between 35–55.
            What other stocks have EXAS investors also bought?
            EXAS Investors also bought SQ, DKNG, ENPH, ZS, TTD, AMAT, BLK, BMY, ABNB, CCL.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ABTAbbott Laboratories
              BMRNBioMarin Pharmaceutical
              CPRXCatalyst Pharma
              CNCCentene
              CORTCorcept Therapeutics
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis